A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma
Clinical trial NCT05220124 · UNKNOWN
Trial details
- NCT number
- NCT05220124
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2024-11-30
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.